We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BLAU3 market cap is 2.17B. The company's latest EPS is BRL 1.3925 and P/E is 8.69.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 364.31M | 439.84M | 429.26M | 359.68M | 465.1M |
| Operating Income | 76M | 152.37M | 39.67M | 48.84M | 72.08M |
| Net Income | 70.79M | 99.4M | 27.68M | 40.09M | 48.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 977.69M | 1.18B | 1.37B | 1.41B | 1.49B |
| Operating Income | 301.48M | 389.13M | 456.62M | 452.19M | 329.44M |
| Net Income | 200.24M | 254.33M | 323.86M | 363.37M | 249.81M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 2.5B | 3.07B | 3.05B | 3.16B | 3.1B |
| Total Liabilities | 630.16M | 1.1B | 1.06B | 1.15B | 1.06B |
| Total Equity | 1.87B | 1.97B | 2B | 2.01B | 2.03B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 738.44M | 1.27B | 2.33B | 2.5B | 3.05B |
| Total Liabilities | 472.69M | 1.05B | 693.16M | 681.11M | 1.06B |
| Total Equity | 265.76M | 221.34M | 1.63B | 1.82B | 2B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | 161.51M | 222.59M | 220.56M | 97.67M | 178.52M |
| Investing | 62.3M | -399.8M | -356.81M | -70.54M | -72.61M |
| Financing | -140.42M | 193.44M | 153.63M | -32.14M | -116.98M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | 221.29M | 226.52M | 153.98M | 171.9M | 220.56M |
| Investing | -197.41M | -220.78M | -870.32M | 132.96M | -356.81M |
| Financing | -75.71M | 57.26M | 698.01M | -342.62M | 153.63M |
| Market Cap | 2.17B |
| Price to Earnings Ratio | 8.69 |
| Price to Sales Ratio | 1.46 |
| Price to Cash Ratio | 68.91 |
| Price to Book Ratio | 1.09 |
| Dividend Yield | 0.12% |
| Shares Outstanding | 179.39M |
| Average Volume (1 week) | 421.34k |
| Average Volume (1 Month) | 286.04k |
| 52 Week Change | -8.47% |
| 52 Week High | 17.61 |
| 52 Week Low | 9.20 |
| Spread (Intraday) | 0.46 (3.69%) |
| Company Name | Blau Farmaceutica SA |
| Address |
rodovia raposo tavares edificio 100 n. 5 2833 cotia, sao paulo |
| Website | https://www.blau.com.br |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
